After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

The Institute for Clinical and Economic Review (ICER) has published its final report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper to meet its value ...

Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments. Spravato has been approved since 2019 for TRD, with its label extended the ...

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Many ...

Most non-prescription medicines are not needed and can be stopped. Equipment: plastic medication syringe or dropper (not a spoon) Child's position: sitting up (never lying down) Place the syringe ...